The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury

Chest

Volumn 141, Issue 5, 2012, Pages 1160-1169

  Kangelaris, Kirsten Neudoerffer ^a,b   Sapru, Anil ^a   Calfee, Carolyn S ^a,b   Liu, Kathleen D ^a,b   Pawlikowska, Ludmila ^a   Witte, John S ^a   Vittinghoff, Eric ^a   Zhuo, Hanjing ^b   Auerbach, Andrew D ^b   Ziv, Elad ^a   Matthay, Michael A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

ACUTE LUNG INJURY; ADULT; AFRICAN AMERICAN; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GROUP DUFFY SYSTEM; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE GENE; EUROPEAN AMERICAN; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN INJURY; OUTCOME ASSESSMENT; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN HOMEOSTASIS; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84860561123     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1766     Document Type: Article

References (52)

1. Esteban A, Anzueto A, Frutos F, et al Mechanical Ventilation International Study Group. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA. 2002;287(3):345-355. (Pubitemid 34251968)
2. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685-1693. (Pubitemid 41464707)
3. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301- 1308.
4. Erickson SE, Shlipak MG, Martin GS, et al National Institutes of Health National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network. Racial and ethnic disparities in mortality from acute lung injury. Crit Care Med.2009;37(1):1-6.
5. Moss M, Mannino DM. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979-1996). Crit Care Med. 2002;30(8):1679-1685. (Pubitemid 34879574)
6. Ness RB, Haggerty CL, Harger G, Ferrell R. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. Am J Epidemiol. 2004;160(11):1033-1038. (Pubitemid 39557455)
7. Mayr FB, Spiel AO, Leitner JM, et al. Duffy antigen modifies the chemokine response in human endotoxemia. Crit Care Med. 2008;36(1):159-165.
8. Piantadosi CA, Schwartz DA. The acute respiratory distress syndrome. Ann Intern Med. 2004;141(6):460-470. (Pubitemid 39281882)
9. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet. 1995;10(2):224-228.
10. UCSC Genome Bioinformatics, Human (Homo sapiens) Genome Browser Gateway for rs2814778. UCSC Genome Bioinformatics website. http://genome.ucsc.edu/cgi- bin/hg Tracks?hgHubConnect.destUrl=.%2Fcgi-bin%2FhgTracks&clade= mammal&org=Human&db=hg19&position=rs2814778 &hgt.suggest= rs2814778&hgt.suggestTrack=knownGene&Submit=submit&hgsid= 244945259&pix=1329. Accessed September 21, 2011.
11. Peiper SC, Wang ZX, Neote K, et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med. 1995;181(4):1311-1317.
12. Cutbush M, Mollison PL. The Duffy blood group system. Heredity (Edinb). 1950;4(3):383-389.
13. Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science. 1993;261(5125):1182-1184. (Pubitemid 23300887)
14. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295(6):302-304.
15. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science. 1975;189(4202):561-563.
16. Welch SG, McGregor IA, Williams K. The Duffy blood group and malaria prevalence in Gambian West Africans. Trans R Soc Trop Med Hyg. Med Hyg (Geneve). 1977;71(4):295-296. (Pubitemid 8164439)
17. Howes RE, Patil AP, Piel FB, et al. The global distribution of the Duffy blood group. Nat Commun. 2011;2:266.
18. Neote K, Mak JY, Kolakowski LF Jr, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood. 1994;84(1):44-52. (Pubitemid 24193803)
19. Lee JS, Frevert CW, Wurfel MM, et al. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol. 2003;170(10):5244-5251. (Pubitemid 36554758)
20. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem. 1993;268(17):12247-12249. (Pubitemid 23182370)
21. Middleton J, Neil S, Wintle J, et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell.1997;91(3):385-395. (Pubitemid 27467969)
22. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest. 1991;88(4):1362-1369.
23. Lee JS, Wurfel MM, Matute-Bello G, et al. The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation. J Immunol. 2006;177(11):8086-8094. (Pubitemid 44846327)
24. Zarbock A, Bishop J, Müller H, et al. Chemokine homeostasis vs. chemokine presentation during severe acute lung injury: the other side of the Duffy antigen receptor for chemokines (DARC). Am J Physiol Lung Cell Mol Physiol.2010;298(3):L462-471.
25. Zarbock A, Schmolke M, Bockhorn SG, et al. The Duffy antigen receptor for chemokines in acute renal failure: A facilitator of renal chemokine presentation. Crit Care Med.2007;35(9):2156-2163. (Pubitemid 47326454)
26. Mangalmurti NS, Xiong Z, Hulver M, et al. Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. Blood. 2009;113(5):1158-1166.
27. Reutershan J, Harry B, Chang D, Bagby GJ, Ley K. DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines. Eur J Immunol. 2009;39(6):1597-1607.
28. Fukuma N, Akimitsu N, Hamamoto H, Kusuhara H, Sugiyama Y, Sekimizu K. A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem Biophys Res Commun. 2003;303(1):137-139. (Pubitemid 36338218)
29. He W, Neil S, Kulkarni H, et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe. 2008;4(1):52-62. (Pubitemid 351944053)
30. Nalls MA, Wilson JG, Patterson NJ, et al. Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. Am J Hum Genet. 2008;82(1):81-87. (Pubitemid 351726080)
31. Reich D, Nalls MA, Kao WH, et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet. 2009;5(1):e1000360.
32. Vergara C, Tsai YJ, Grant AV, et al. Gene encoding Duffy antigen/receptor for chemokines is associated with asthma and IgE in three populations. Am J Respir Crit Care Med.2008;178(10):1017-1022.
33. Ramsuran V, Kulkarni H, He W, et al. Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women. Clin Infect Dis. 2011;52(10):1248-1256.
34. Brower RG, Lanken PN, MacIntyre N, et al National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327-336.
35. Wiedemann HP, Wheeler AP, Bernard GR, et al National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564-2575. (Pubitemid 43882352)
36. 2-agonist for treatment of acute lung injury. Am J Respir Crit Care Med.2011;184(5):561-568.
37. Bernard GR, Artigas A, Brigham KL, et al. The American- European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 pt 1):818-824. (Pubitemid 24082248)
38. Livak KJ. SNP genotyping by the 5′-nuclease reaction. Methods Mol Biol. 2003;212:129-147.
39. Kim H, Hysi PG, Pawlikowska L, et al. Population stratification in a case-control study of brain arteriovenous malformation in Latinos. Neuroepidemiology. 2008;31(4):224-228.
40. Schoenfeld DA, Bernard GR; ARDS Network. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30(8):1772-1777. (Pubitemid 34879589)
41. Bernard GR, Wheeler AP, Arons MM, et al The Antioxidant in ARDS Study Group. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. Chest. 1997;112(1):164-172. (Pubitemid 27343614)
42. Nickel RG, Willadsen SA, Freidhoff LR, et al. Determination of Duffy genotypes in three populations of African descent using PCR and sequence-specific oligonucleotides. Hum Immunol. 1999;60(8):738-742. (Pubitemid 29380045)
43. Tsai HJ, Choudhry S, Naqvi M, Rodriguez-Cintron W, Burchard EG, Ziv E. Comparison of three methods to estimate genetic ancestry and control for stratification in genetic association studies among admixed populations. Hum Genet.2005;118(3-4):424-433. (Pubitemid 43091213)
44. Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics. 2003;164(4):1567-1587. (Pubitemid 37102217)
45. Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: dominant markers and null alleles. Mol Ecol Notes. 2007;7(4):574-578. (Pubitemid 47035522)
46. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics.2000;155(2):945-959. (Pubitemid 30397141)
47. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619-1636.
48. Lautenberger JA, Stephens JC, O'Brien SJ, Smith MW. Significant admixture linkage disequilibrium across 30 cM around the FY locus in African Americans. Am J Hum Genet.2000;66(3):969-978. (Pubitemid 30470498)
49. Freedman DS, Gates L, Flanders WD, et al. Black/white differences in leukocyte subpopulations in men. Int J Epidemiol.1997;26(4):757-764. (Pubitemid 27367851)
50. Weissman JS, Stern R, Fielding SL, Epstein AM. Delayed access to health care: risk factors, reasons, and consequences. Ann Intern Med. 1991;114(4):325-331.
51. Iwamoto S, Li J, Sugimoto N, Okuda H, Kajii E. Characterization of the Duffy gene promoter: evidence for tissue-specific abolishment of expression in Fy(a-b-) of black individuals. Biochem Biophys Res Commun. 1996;222(3):852-859. (Pubitemid 26194841)
52. Olsson ML, Hansson C, Avent ND, Akesson IE, Green CA, Daniels GL. A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele-specific primers. Transfusion. 1998;38(2):168-173 (Pubitemid 28145083)